Importantly, this therapeutic effect was accompanied by profound remodeling of the tumor immune microenvironment, characterized by the recruitment of preS1‐specific B cells, enhanced infiltration of adaptive immune subsets (CD3+, CD4+, and CD8+ T cells), and activation of innate immune cells (NK cells, DCs, and neutrophils). Here, CD4 is linked to neoplasm.